<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0803210592
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SINGULAIR
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MONTELUKAST SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        111.20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MERCK SHARP &amp; DOHME" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MERCK SHARP & DOHME
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Organon Pharma UK Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R03DC03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->for What Singulair is</p><p>Singulair is a leukotriene receptor antagonist that blocks substances called leukotrienes.</p><p>&nbsp;</p><p>How Singulair works</p><p>Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms. By blocking leukotrienes, Singulair improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).</p><p>&nbsp;</p><p>When Singulair should be used</p><p>Your doctor has prescribed Singulair to treat asthma, preventing your asthma symptoms during the day and night.</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Singulair is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled on their medication and need additional therapy.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Singulair also helps prevent the narrowing of airways triggered by exercise.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->In those asthmatic patients in whom Singulair is indicated in asthma, Singulair can also provide symptomatic relief of seasonal allergic rhinitis.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Singulair is used to treat outdoor allergies that happen part of the year (seasonal allergic rhinitis) in adults and adolescents 15 years of age and older</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Singulair is used to treat indoor allergies that happen all year (perennial allergic rhinitis) in adults and adolescents 15 years of age and older</p><p>&nbsp;</p><p>&nbsp;</p><p>Your doctor will determine how Singulair should be used depending on the symptoms and severity of your asthma.</p><p>&nbsp;</p><p>What is asthma?</p><p>Asthma is a long-term disease. Asthma includes:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->difficulty breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->swelling (inflammation) in the lining of airways.</p><p>Symptoms of asthma include: Coughing, wheezing, and chest tightness.</p><p>&nbsp;</p><p>What are seasonal allergies?</p><p>Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic response often caused by airborne pollens from trees, grasses and weeds. The symptoms of seasonal allergies typically may include: stuffy, runny, itchy nose; sneezing; watery, swollen, red, itchy eyes.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Tell your doctor about any medical problems or allergies you have now or have had.</p><p>&nbsp;</p><p>Do not take Singulair</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->if you are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor or pharmacist before taking Singulair.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->If your asthma or breathing gets worse, tell your doctor immediately.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Oral Singulair is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you. Always have your inhaled rescue medicine for asthma attacks with you.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->It is important that you or your child take all asthma medications prescribed by your doctor. Singulair should not be substituted for other asthma medications your doctor has prescribed for you.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Any patient on anti-asthma medicines should be aware that if you develop a combination of symptoms such as a flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->You should not take acetyl-salicylic acid (aspirin) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they make your asthma worse.</p><p>&nbsp;</p><p>Children and adolescents</p><p>Do not give this medicine to children less than 15 years of age.</p><p>&nbsp;</p><p>There are different form(s) of this medicine available for paediatric patients under 18 years of age based on age range.</p><p>&nbsp;</p><p>Other medicines and Singulair</p><p>Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines including those obtained without a prescription.</p><p>Some medicines may affect how Singulair works, or Singulair may affect how other medicines work. Tell your doctor if you are taking the following medicines before starting Singulair:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->phenobarbital (used for treatment of epilepsy)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->phenytoin (used for treatment of epilepsy)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->rifampicin (used to treat tuberculosis and some other infections)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->gemfibrozil (used for treatment of high lipid levels in plasma)</p><p>&nbsp;</p><p>Singulair with food and drink</p><p>Singulair 10 mg film-coated tablet may be taken with or without food.</p><p>&nbsp;</p><p>Pregnancy and breast-feeding</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Singulair.</p><p>&nbsp;</p><p><u>Pregnancy</u></p><p>Your doctor will assess whether you can take Singulair during this time.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known if Singulair appears in breast milk. You should consult your doctor before taking Singulair if you are breast-feeding or intend to breast-feed.</p><p>&nbsp;</p><p>Driving and using machines</p><p>Singulair is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported with Singulair may affect some patients&rsquo; ability to drive or operate machinery.</p><p>&nbsp;</p><p>Singulair 10 mg film-coated tablets contain lactose</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->You should take only one tablet of Singulair once a day as prescribed by your doctor.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->It should be taken even when you have no symptoms or have an acute asthma attack.</p><p>&nbsp;</p><p>For adults and adolescents 15 years of age and older:</p><p>The recommended dose is one 10 mg tablet to be taken daily in the evening.</p><p>If you are taking Singulair, be sure that you do not take any other products that contain the same active ingredient, montelukast.</p><p>&nbsp;</p><p>This medicine is for oral use.</p><p>You can take SINGULAIR 10 mg with or without food.</p><p>&nbsp;</p><p>If you take more Singulair than you should</p><p>Contact your doctor immediately for advice.</p><p>There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.</p><p>&nbsp;</p><p>If you forget to take Singulair</p><p>Try to take Singulair as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p>If you stop taking Singulair</p><p>Singulair can treat your asthma only if you continue to take it.</p><p>It is important to continue taking Singulair for as long as your doctor prescribes. It will help control your asthma.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>In clinical studies with Singulair 10 mg film-coated tablets, the most commonly reported side effects (occurring in at least 1 of 100 patients and less than 1 of 10 patients treated) thought to be related to Singulair were:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->abdominal pain</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->headache</p><p>These were usually mild and occurred at a greater frequency in patients treated with Singulair than placebo (a pill containing no medication).</p><p>&nbsp;</p><p>The frequency of possible side effects listed below is defined using the following convention: Very common: may affect more than 1 in 10 people</p><p>Common: may affect up to 1 in 10 people Uncommon: may affect up to 1 in 100 people Rare: may affect up to 1 in 1,000 people</p><p>Very rare: may affect up to 1 in 10,000 people</p><p>Not known: frequency cannot be estimated from the available data</p><p>&nbsp;</p><p>Additionally, while the medicine has been on the market, the following have been reported:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->upper respiratory infection (<em>Very</em><em> common</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->increased bleeding tendency (<em>Rare</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->allergic reactions including swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing (<em>Uncommon</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->behaviour and mood related changes [dream abnormalities, including nightmares, trouble sleeping, sleep walking, irritability, feeling anxious, restlessness, agitation including aggressive behaviour or hostility, depression (<em>Uncommon</em>); tremor, disturbance in attention, memory impairment (<em>Rare</em>); hallucinations, disorientation, suicidal thoughts and actions (<em>Very</em><em> rare</em>)]</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dizziness, drowsiness, pins and needles/numbness, seizure <em>(Uncommon)</em></p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->palpitations (<em>Rare</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->nosebleed (<em>Uncommon</em>), swelling (inflammation) of the lungs <em>(Very rare)</em></p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->diarrhoea, nausea, vomiting (<em>Common</em>); dry mouth, indigestion (<em>Uncommon</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->hepatitis (inflammation of the liver) (<em>Very</em><em> rare</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->rash <em>(Common)</em>; bruising, itching, hives (<em>Uncommon</em>); tender red lumps under the skin most commonly on your shins (erythema nodosum), severe skin reactions (erythema multiforme) that may occur without warning (<em>Very</em><em> rare</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->joint or muscle pain, muscle cramps (<em>Uncommon</em>)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->fever (<em>Common</em>); weakness/tiredness, feeling unwell, swelling (<em>Uncommon</em>)</p><p>&nbsp;</p><p>In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) have been reported. You must tell your doctor right away if you get one or more of these symptoms (See section 2).</p><p>&nbsp;</p><p>Reporting of side effects</p><p>If your child gets any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via &ldquo;The National Pharmacovigilance and Drug Safety Centre (NPC), SFDA&rdquo;. By reporting side affects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Keep this medicine out of the sight and reach of children.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not use this medicine after the expiry date which is stated on the blister after EXP. The first two numbers indicate the month; the last four numbers indicate the year. The expiry date refers to the last date of that month.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Store below 30&deg;C.</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->What Singulair contains</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The active substance is montelukast. Each tablet contains montelukast sodium which corresponds to 10 mg of montelukast.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->The other ingredients are:</p><p>Microcrystalline cellulose, lactose monohydrate (89.3 mg), croscarmellose sodium, hyprolose (E 463), and magnesium stearate.</p><p>Film coating: hypromellose, hyprolose (E 463), titanium dioxide (E 171), red and yellow ferric oxide (E 172), and carnauba wax.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Singulair looks like and contents of the pack10 mg Singulair tablets are beige, rounded square, film-coated with SINGULAIR engraved on one side, MSD 117 on the other.Blisters in packages of: 7, 10, 14, 20, 28, 30, 50, 56, 84, 90, 98, 100, 140, and 200 tablets. Blisters (unit dose), in packages of: 49x1, 50x1 and 56x1 tabletsNot all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p><strong>Marketing</strong><strong> </strong><strong>Authorization</strong><strong> Holder: </strong></p><p>Merck Sharp &amp; Dohme Limited, Hertford Road,</p><p>Hoddesdon, Hertfordshire EN11 9BU,</p><p>UK.</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>Merck Sharp &amp; Dohme Limited, Shotton Lane,</p><p>Cramlington, Northumberland, NE23 3JU,</p><p>UK.</p><p>&nbsp;</p><p><strong>Packed by:</strong></p><p>Pharma Pharmaceutical Industries,</p><p>Second Industrial Area,</p><p>P.O. Box 11351 Riyadh, Saudi Arabia</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This package leaflet was last revised on September 2015Version No. (02)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>ماهو سينقولير </strong></p><p>يُعتبَر سينقولير مُضاد مُستقبل لوكترين يُحصر المواد المعروفة باللوكترين.</p><p><strong>كيف يعمل سينقولير </strong></p><p>تُسبّب اللوكترين تضييق المجاري التنفسية في الرئتَيْن وتورّمها. كما تُسبّب أعراض الحساسيّة. من خلال إحصار اللوكترين، يُحسّن سينقولير عوارض الربو ويُساعد على السيطرة عليها ويُحسّن أعراض الحساسيّة الموسميّة (المعروفة أيضًا بحمى القشّ أو التهاب الأنف التحسّسي الموسمي).</p><p>&nbsp;</p><p><strong>متى يجب استخدام سينقولير </strong></p><p>إن هذا الدواء قد تم صرفه خصيصًا لمعالجة الربو، ليمنع ظهور أعراض الربو ليلاً ونهارًا.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُستخدَم سينقولير لمعالجة المرضى البالغين والمراهقين من سن 15 سنة الذين لا يتحكّمون بمرضهم بشكل ملائم من خلال الأدوية ويحتاجون إلى علاج إضافي.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->كما يُساعد سينقولير على الوقاية من ضيق المجاري التنفسيّة الذي يُسبّبه بذل مجهود عضلي.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بالنسبة إلى المرضى المُصابين بداء الربو الذين يوصَف لهم سينقولير، يُمكن أن يُخفّف أيضا من أعراض التهاب الأنف التحسسي الموسمي.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُستخدَم سينقولير لمعالجة الحساسية التي تحدث في الهواء الطلق خلال جزء من السنة (حساسية الأنف الموسمية) لدى البالغين والمراهقين من سن 15 سنة من العمر وكبار السن.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُستخدَم سينقولير لمعالجة الحساسية التي تحدث في الداخل طوال العام (التهاب الأنف التحسسي الدائم) لدى البالغين والمراهقين 15 سنة من العمر وكبار السن.</p><p>سيُحدّد الطبيب طريقة استخدام سينقولير كعلاج حسب أعراض الربو لديك وحدّتها.</p><p><strong>&nbsp;</strong></p><p><strong>ما هو داء الربو؟</strong></p><p>الربو داء طويل الأمد.</p><p>يشمل الربو:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صعوبة في التنفّس بسبب ضيق المجاري التنفسيّة. يسوء هذا الضيق ويتحسَّن حسب الظروف المختلفة.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->المجاري التنفسيّة الحسّاسة التي تتفاعل مع عدّة عوامل، مثل دخان السيجارة، أو حبوب اللقاح، أو الهواء البارد، أو المجهود العضلي.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->التهاب (تورّم) بطانة المجاري التنفسيّة.</p><p>&nbsp;</p><p>تشمل أعراض الربو: السُعال، والصفير عند التنفّس، وضيق في الصدر.</p><p>&nbsp;</p><p><strong>ما هي الحساسيّة الموسميّة؟</strong></p><p>الحساسيّة الموسميّة (المعروفة أيضًا بحمى القشّ أو التهاب الأنف التحسّسي الموسمي) ردّة فعل حساسيّة غالبًا ما يُسبّبها حبوب اللّقاح المحمولة جوًّا والمنقولة من الأشجار، والنباتات، والأعشاب. قد تشمل أعراض الحساسيّات الموسميّة: الأنف المسدود، الرشح والحكة قي الأنف؛ والعطاس؛ واحمرار العيون وتورّمها وزيادة افراز الدموع والحكة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>اخبر الطبيب على أي حساسيّة أو مشكلة طبيّة في الماضي أو في الحاضر.</p><p>&nbsp;</p><p><strong>لا تتناول </strong><strong>سينقولير إذا كنت:</strong></p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تُعاني من حساسيّة (أو حساسيّة مفرطة) من مونتيليوكاست أو من أيّ مكوّنات أخرى من سينقولير (اقرأ البند 6).</p><p><strong>&nbsp;</strong></p><p><strong>التحذيرات والاحتياطات</strong></p><p><strong>اتصل بالطبيب أو الصيدلي قبل </strong><strong>تناول </strong><strong>سينقولير.</strong></p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا ساءت أعراض الربو أو التنفّس لديك ، اتّصل بالطبيب فورًا.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا يهدف سينقولير إلى معالجة نوبات الربو الحادة. في حال حدوث نوبة، يُرجى اتّباع تعليمات الطبيب. يجب أن يُلازمك جهاز الاستنشاق الانقاذي دائمًا في حال تعرّضك لنوبات ربو.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->من الضروري أن تتناول أو طفلك أدوية الربو كلّها التي وصفها طبيبك. يجب عدم استخدام سينقولير بدلًا عن أدوية ربو أخرى وصفها الطبيب لطفلك.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->على المريض الذي يتناول أدوية مُضادة للربو أن يُدرك أنّه في حال تطوّرت مجموعة أعراض، مثل أعراض الرشح، أو الوخزات أو التنميل في الذراعَيْن والساقَيْن، وتدهور حال الأعراض الرئويّة، و/أو الطفح الجلدي، يجب استشارة الطبيب.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يجب عدم تناول حَمْض الأستيل سلسيليك (الأسبرين) أو الأدوية المُضادة للالتهابات (المعروفة أيضًا بالأدوية المُضادة للالتهابات اللاستيرويديّة) في حال كانت تزيد من أعراض الربو لديك.</p><p><strong>&nbsp;</strong></p><p><strong>الأطفال والمراهقين</strong></p><p>لا تُعطِ الدواء للأطفال أقل من عمر عمر 15 عام.</p><p>هناك أشكال صيدلانية مختلفة لهذا الدواء للمرضى الأطفال تحت عمر 18 سنة على أساس الفئة العمرية</p><p>&nbsp;</p><p><strong>تناول أدوية أخرى مع سينقولير </strong></p><p>يُرجى إطلاع الطبيب أو الصيدلي في حال كنت تتناول ، في الماضي أو في الحاضر، أدوية أخرى، بما في ذلك تلك الأدوية من دون وصفة طبيّة.</p><p>قد تؤثّر بعض الأدوية على مفعول سينقولير وقد يؤثّر سينقولير على مفعول أدوية أخرى.</p><p>اخبر الطبيب إذا كان طفلك يتناول الأدوية التالية قبل البدء بتناول سينقولير:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فينوباربيتال (المستخدَم لمعالجة داء الصرع)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->فينيتوين (المستخدَم لمعالجة داء الصرع)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ريفامبيسين (المستخدَم لمعالجة داء السّلّ وبعض الالتهابات الأخرى)</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->جمفبرويزل (المستخدم لمعالجة متسويات دهون مرتفعة في البلازما)</p><p>&nbsp;</p><p><strong>تناول سينقولير مع الطعام أو الشراب</strong></p><p>يُمكن تناول سينقولير 10 ملغم أقراص مغلفة مع / أو من دون طعام.</p><p><strong>&nbsp;</strong></p><p><strong>الحمل والرضاعة</strong></p><p>إذا كنتِ حاملًا أو مرضعًا، أو تعتقدين بأنك حاملًا أو تنوين الإنجاب، استشيري الطبيب أو الصيدلي ليقدم لك النصيحة قبل تناول سينقولير</p><p>&nbsp;</p><p><em>الاستخدام &nbsp;أثناء الحمل</em></p><p>سيُقيّم الطبيب إذا كان باستطاعتك تناول سينقولير في هذه المرحلة.</p><p>&nbsp;</p><p><em>الاستخدام أثناء الرضاعة</em></p><p>من غير المعروف إذا كان سينقولير ينتقل إلى حليب الأم. عليك استشارة الطبيب قبل تناول سينقولير إذا كنت تُرضعين أو تنوين الرضاعة.</p><p><strong>&nbsp;</strong></p><p><strong>القيادة واستخدام الآليّات</strong></p><p>لا يُتوقَّع أن يؤثّر سينقولير على قدرتك على القيادة أو على تشغيل الآليّات. لكن، قد تختلف الردود الفرديّة على الأدوية. قد تؤثّر بعض الآثار الجانبيّة (مثل الدوخة والنُعاس) التي تمّ الابلاغ عنها بشكل نادرٍ جدًّا مع سينقولير على قدرة بعض المرضى على القيادة أو تشغيل الآليّات.</p><p><strong>&nbsp;</strong></p><p><strong>تحتوي أقراص سينقولير 10 ملغم المغلفة المغلفة على الاكتوز</strong></p><p>في حال اخبرك الطبيب أنّه لديك عدم تقبّل لبعض السكريّات، عليك الإتصال به قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول سينقولير دائمًا بناءً على وصفة الطبيب. عليك مراجعة الطبيب أو الصيدلي في حال لم تكن متأكّدًا</p><p>- تناول قرصًا واحدًا فقط من سينقولير مرةً واحدةً في اليوم حسب وصفة الطبيب.</p><p>- يجب تناول الدواء وإن لم تُعانِ من أيّ أعراض أو إن حصلت لك نوبة ربو حادة.</p><p>&nbsp;</p><p><strong>بالنسبة للبالغين والمراهقين ابتداءً من عمر 15 عام</strong></p><p>يؤخذ قرصًا واحدًا تركيز 10 ملغم يوميًّا مساءً.</p><p>في حال كنت تتناول سينقولير، احرص على عدم تناول أي منتجات أخرى تحتوي على المادة الفعالة نفسها، مونتيليوكاست.</p><p>هذا الدواء للتناول عن طريق الفم</p><p>يُمكن أخذ سينقولير 10 ملغم مع تناول الطعام أو من دونه.</p><p>&nbsp;</p><p><strong>في حال تناول جرعة زائدة من سينقولير </strong></p><p>عليك الاتصال فورًا بالطبيب للحصول على مشورته.</p><p>لم يتم الإبلاغ عن أعراض جانبيّة في غالبيّة تقارير الجرعة الزائدة. تشمل الأعراض الأكثر شيوعًا التي تم الإبلاغ عنها للجرعة الزائدة لدى الكبار والأطفال ألمًا في البطن، والنُعاس، والعطش، والصداع، والتقيؤ، والنشاط المُفرَط.</p><p>&nbsp;</p><p><strong>في حال نسيت تناول سينقولير </strong></p><p>حاول تناول سينقولير بحسب الوصفة. لكن، في حال نسيت تناول الجرعةً، استأنف الجدول الزمني المُعتاد على أساس قرص واحد يوميًّا.</p><p>لا تتناول جرعةً مضاعفةً للتعويض عن الجرعة المنسيّة.</p><p>&nbsp;</p><p><strong>في حال توقّفت عن تناول سينقولير </strong></p><p>لا يُمكن لسينقولير معالجة داء الربو لديك إلّا في حال تابع طفلك تناوله.</p><p>من الضروري مواصلة تناول سينقولير للمدّة التي وصفها الطبيب له. سيُساعدك ذلك في السيطرة على داء الربو لديك.</p><p>في حال كان لديك أسئلة إضافيّة حول استخدام هذا المُنتَج، اتّصل بالطبيب أو بالصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>على غرار الأدوية كلّها، يُمكن أن يُسبّب سينقولير أعراضًا جانبيةً وإن كانت لا تُصيب الجميع.</p><p>&nbsp;</p><p>في الدراسات السريريّة على أقراص سينقولير 10 ملغم المغلفة، الأعراض الجانبيّة التي تم الإبلاغ عنها الأكثر شيوعًا (التي تحدث لدى 1 من أصل 100 مريض على الأقل ولدى أقلّ من 1 من أصل 10 مرضى مُعالجين) التي يُعتقد بأنّها مرتبطة بسينقولير هي:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم في البطن</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صُداع</p><p>كانت هذه الأعراض بالأغلب معتدلة، تكرّرت بوتيرة أعلى لدى المرضى المُعالجين بسينقولير، مقارنةً بقرص العلاج الذي لا يحتوي على المادة الفعّالة.</p><p>&nbsp;</p><p>يتمّ تحديد وتيرة الأعراض الجانبيّة المحتملة المُدرجة أدناه وفق التعريفات التالية:</p><p>شائعة جدًا (تؤثّر على &nbsp;أكثر من واحد من أصل 10 مرضى)</p><p>شائعة (تؤثّر على واحد من أصل &nbsp;10 مرضى)</p><p>غير شائعة (تؤثّر على واحد من أصل100 مريض)</p><p>نادرة (تؤثّر على واحد من أصل 1000 مريض)</p><p>نادرة جدًّا (تؤثّر على واحد من أصل 10000 مريض)</p><p>غير معروفة: لا يُمكن تقدير تكرارها إنطلاقًا من البيانات المتوفّرة</p><p>&nbsp;</p><p>بالإضافة إلى ذلك، تمّ الابلاغ عن الأعراض الجانبيّة التالية بينما كان الدواء مطروحًا في السوق:</p><p>- التهاب الجهاز التنفسي العلوي (<em>شائعة جدًا</em>)</p><p>- زيادة احتمالية النزف (<em>نادرة</em>)</p><p>- ردود الفعل الحساسيّة، بما في ذلك تورّم الوجه، والشفتَيْن، واللسان، و/أو الحنجرة التي قد تُسبّب صعوبةً في التنفّس أو البلع (<em>غير شائعة</em>)</p><p>- تبدّل السلوك والتغيّرات المزاجيّة (الأحلام غير الاعتياديّة، بما في ذلك الكوابيس، واضطرابات النوم، والمشي أثناء النوم والإنزعاج، والشعور بالتوتّر، والأرق، والاضطراب، بما في ذلك السلوك العدائي أو العداوة، والاكتئاب (<em>غير شائعة</em>)؛ والرُعاش، والخلل في التركيز، والخلل في الذاكرة (<em>نادرةً</em>)؛ والهلوسات، والارتباك، والأفعال والأفكار الانتحاريّة (<em>نادرة جدًّا</em>)؛</p><p>- الدوار، والنُعاس، والوخزات والإبر/التنميل، والتشنجات (<em>غير شائعة</em>)؛</p><p>- خفقان القلب (<em>نادرةً</em>)؛</p><p>- نزيف الأنف (<em>غير شائعة</em>)، تورم (التهاب) الرئتَيْن (<em>نادرة جدًّا</em>)؛</p><p>- الإسهال، الغثيان، التقيّؤ (<em>شائعة</em>)؛ جفاف الفم، عُسر الهضم (<em>غير شائعة</em>)؛</p><p>- التهاب الكبد (<em>نادرة جدًّا</em>)؛</p><p>- الطفح الجلدي (<em>شائعة</em>)؛ التكّدم، &nbsp;الحكة، الشرى (<em>غير شائعة</em>)؛ حمامى عقدة (عُقَد حمراء تحت الجلد مؤلمة، تكون في غالبيّة الحالات على الساق)، ردود فعل جلديّة حادّة (حُمامى عديدة الأشكال) قد تطرأ من دون سابق إنذار (<em>نادرة جدًّا</em>)؛</p><p>- ألم في المفاصل أو في العضلات، تشنّجات عضليّة (<em>غير شائعة</em>)؛</p><p>- حمى (<em>شائعة</em>)؛ وهن/تعب، شعور بالانزعاج، تورّم (<em>غير شائعة</em>).</p><p>لدى المرضى المُصابين بالربو والمُعالجين بالمونتيليوكاست، تمّ الابلاغ عن حالات نادرة جدًّا من مجموعة أعراض، مثل أعراض الرشح والوخزات/التنميل في الذراعَيْن والساقَيْن، وازدياد الأعراض الرئويّة سوءًا و/أو الطفح الجلدي (متلازمة شيرغ &ndash; ستراوس). عليك إطلاع طبيبك مباشرةً في حال تعرّض طفلك لأحد هذه الأعراض أو أكثر (انظر البند2).</p><p>&nbsp;</p><p><strong>الإبلاغ عن الأعراض الجانبيّة</strong></p><p>في حال تعرّض طفلك لأعراض جانبيّة، يُرجى التحدّث إلى الطبيب، أو الصيدلي، أو الممرّضة. يشمل ذلك أي أعراض جانبيّة مُحتملة غير مُدرجة في هذه اللائحة. يمكنك الإبلاغ عن الأعراض الجانبية عن طريق &quot;المركز الوطني للتيقظ والسلامة الدوائية، التابع للهيئة العامة للغذاء والدواء&quot;. من خلال الإبلاغ عن الآثار الجانبيّة، يساهم ذلك في إعطاء المزيد من المعلومات عن سلامة هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُحفظ بعيدًا عن متناول أيدي ومرأى الأطفال.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يُحفظ في درجة حرارة أقل من ٣۰ درجة مئوية.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لا تستخدم هذا الدواء بعد انقضاء التاريخ الوارد من خلال الستة أرقام التي تلي EXP على الشريط. يُشير الرقمان الأولان إلى الشهر، &nbsp;والأربع أرقام الأخيرة إلى السنة. تنتهي صلاحيّة الدواء في نهاية الشهر المذكور.</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->يجب عدم التخلّص من الأدوية عبر النفايات المنزليّة أو مياه الصرف الصحي. يُرجى مراجعة الصيدلي لمعرفة كيفيّة التخلّص من الأدوية غير المستعملة. ومن شأن هذه الإجراءات أن تُساهم في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>محتوى سينقولير </strong></p><p>- المادة الفعالة هي مونتيليوكاست. يحتوي كل قرص على صوديوم مونتيليوكاست الذي يُعادل 10 ملغم مونتيليوكاست.</p><p>- المكوّنات الأخرى هي: سليولوز دقيق التبلور، لاكتوز أحادي الهيدرات (89.3 &nbsp;ملغم)، كروسكارميلوز صوديوم، هيبرولوز (E 463)، ، وستيارات المغنسيوم.</p><p>- يتكوّن الغلاف من: هيبروميللوز، هيبرومللوز (E 463)، ثاني اكسيد التيتانيوم (E171)، أكسيد الحديد الأحمر والأصفر (E 172)، وشمع الكارنوبا.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أشكال سينقولير ومحتوى العلبةأقراص سينقولير 10 ملغم المغلفة، ذات لون البيج، مربّعة مدوّرة، مغلّفة، مع كلمة سينقولير SINGULAIR محفورة عليها من جهة و117 MSD على الجهة الأخرى. الأشرطة في عبوات من: 7، و10، 14، و20، و28، و30، و50، و56، و84، و90، و98، و100، و140، و200 قرص.الأشرطة (الجرعات الفرديّة) في عبوات من 49x1، و50x1، و56x1 قرصًا.قد لا يتم تسويق جميع أحجام العبوات.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>الشركة المالكة لحقوق التسويق: </strong></p><p>ميرك شارب ودوم المحدودة،</p><p>طريق هيرتفورد، هوديسدون، هيرتفوردشاير</p><p>&nbsp;أي أن ١١ ٩ بي يو، المملكة المتحدة</p><p>&nbsp;</p><p><strong>الشركة </strong><strong>الصانعة</strong><strong>:</strong></p><p>ميرك شارب ودوم ليميتد، شوتون لين،</p><p>كراملينجتون، نورثمبرلاند، إن إي ٣٣٢جي يو،</p><p>المملكة المتحدة</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>التغليف بواسطة:</strong></p><p>فارما للصناعات الدوائية<br />المنطقة الصناعية الثانية،<br />ص ب: 11351 الرياض، المملكة العربية السعودية</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمّت آخر مراجعة لهذة النشرة بتاريخ سيبتمبر 2015الإصدار رقم (2)
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Singulair® 10 mg film-coated tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One film-coated tablet contains montelukast sodium, which is equivalent to 10 mg montelukast.  Excipient with known effect: This medicine contains 89.3 mg lactose monohydrate per tablet.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.

Beige, rounded square, film-coated, size 7.9 mm x 7.9 mm with SINGULAIR engraved on one side and MSD 117 on the other.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Singulair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom &ldquo;as-needed&rdquo; short acting b-agonists provide inadequate clinical control of asthma. In those asthmatic patients in whom Singulair is indicated in asthma, Singulair can also provide symptomatic relief of seasonal allergic rhinitis.</p><p>Singulair is also indicated in the prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstriction.</p><p>Singulair is indicated for the relief of symptoms of seasonal allergic rhinitis and perennial allergic rhinitis in patients 15 years of age and older.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>The recommended dose for adults and adolescents 15 years of age and older with asthma, or with asthma and concomitant seasonal allergic rhinitis, is one 10 mg tablet daily to be taken in the evening.</p><p>&nbsp;</p><p><u>General recommendations</u></p><p>The therapeutic effect of Singulair on parameters of asthma control occurs within one day.&nbsp;&nbsp; Singulair may be taken with or without food.&nbsp; Patients should be advised to continue taking Singulair even if their asthma is under control, as well as during periods of worsening asthma.&nbsp; Singulair should not be used concomitantly with other products containing the same active ingredient, montelukast.</p><p>&nbsp;</p><p>No dosage adjustment is necessary for the elderly, or for patients with renal insufficiency, or mild to moderate hepatic impairment.&nbsp; There are no data on patients with severe hepatic impairment.&nbsp; The dosage is the same for both male and female patients.</p><p>&nbsp;</p><p><u>Therapy with Singulair in relation to other treatments for asthma</u> Singulair can be added to a patient&rsquo;s existing treatment regimen.</p><p>&nbsp;</p><p><em>Inhaled corticosteroids: &nbsp;</em>Treatment with Singulair can be used as add-on therapy in patients when inhaled corticosteroids plus &ldquo;as needed&rdquo; short acting b-agonists provide inadequate clinical control. Singulair should not be abruptly substituted for inhaled corticosteroids (see section 4.4).</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>Do not give Singulair 10 mg film-coated tablets to children less than 15 years of age. The safety and efficacy of Singulair 10 mg film-coated tablets in children less than 15 years has not been established.</p><p>&nbsp;</p><p>5 mg chewable tablets are available for paediatric patients 6 to 14 years of age. 4 mg chewable tablets are available for paediatric patients 2 to 5 years of age. 4 mg granules are available for paediatric patients 6 months to 5 years of age.</p><p>&nbsp;</p><p><u>Method of administration</u> Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be advised never to use oral montelukast to treat acute asthma attacks and to keep their usual appropriate rescue medication for this purpose readily available. If an acute attack occurs, a short-acting inhaled b-agonist should be used.&nbsp; Patients should seek their doctors&#39; advice as soon as possible if they need more inhalations of short-acting b-agonists than usual.</p><p>&nbsp;</p><p>Montelukast should not be substituted abruptly for inhaled or oral corticosteroids.</p><p>&nbsp;</p><p>There are no data demonstrating that oral corticosteroids can be reduced when montelukast is given concomitantly.</p><p>&nbsp;</p><p>In rare cases, patients on therapy with anti-asthma agents including montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg- Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy.&nbsp; These cases have been sometimes associated with the reduction or withdrawal of oral corticosteroid therapy. Although a causal relationship with leukotriene receptor antagonism has not been established, physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. Patients who develop these symptoms should be reassessed and their treatment regimens evaluated.</p><p>&nbsp;</p><p>Treatment with montelukast does not alter the need for patients with aspirin-sensitive asthma to avoid taking aspirin and other non-steroidal anti-inflammatory drugs.</p><p>&nbsp;</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Montelukast may be administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma. In drug-interactions studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following medicinal products:</p><p>&nbsp;</p><p>theophylline, prednisone, prednisolone, oral contraceptives (ethinyl estradiol/norethindrone 35/1), terfenadine, digoxin and warfarin.</p><p>&nbsp;</p><p>The area under the plasma concentration curve (AUC) for montelukast was decreased approximately 40% in subjects with co-administration of phenobarbital.&nbsp; Since montelukast is metabolised by</p><p>CYP 3A4, 2C8, and 2C9, caution should be exercised, particularly in children, when montelukast is co-administered with inducers of CYP 3A4, 2C8, and 2C9, such as phenytoin, phenobarbital and rifampicin.</p><p>&nbsp;</p><p><em>In vitro </em>studies have shown that montelukast is a potent inhibitor of CYP 2C8.&nbsp; However, data from a clinical drug-drug interaction study involving montelukast and rosiglitazone (a probe substrate representative of medicinal products primarily metabolized by CYP 2C8) demonstrated that montelukast does not inhibit CYP 2C8 <em>in vivo. </em>Therefore, montelukast is not anticipated to markedly alter the metabolism of medicinal products metabolised by this enzyme (e.g., paclitaxel, rosiglitazone, and repaglinide).</p><p>&nbsp;</p><p><em>In vitro </em>studies have shown that montelukast is a substrate of CYP 2C8, and to a less significant extent, of 2C9, and 3A4. In a clinical drug-drug interaction study involving montelukast and gemfibrozil (an inhibitor of both CYP 2C8 and 2C9) gemfibrozil increased the systemic exposure of montelukast by 4.4-fold. No routine dosage adjustment of montelukast is required upon co- administration with gemfibrozil or other potent inhibitors of CYP 2C8, but the physician should be aware of the potential for an increase in adverse reactions.</p><p>&nbsp;</p><p>Based on <em>in vitro </em>data, clinically important drug interactions with less potent inhibitors of CYP 2C8 (e.g., trimethoprim) are not anticipated. Co-administration of montelukast with itraconazole, a strong inhibitor of CYP 3A4, resulted in no significant increase in the systemic exposure of montelukast.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Animal studies do not indicate harmful effects with respect to effects on pregnancy or embryonal/foetal development.</p><p>&nbsp;</p><p>Limited data from available pregnancy databases do not suggest a causal relationship between Singulair and malformations (i.e. limb defects) that have been rarely reported in worldwide post- marketing experience.</p><p>Singulair may be used during pregnancy only if it is considered to be clearly essential. <u>Breast-feeding</u></p><p>Studies in rats have shown that montelukast is excreted in milk (see section 5.3). It is unknown</p><p>whether montelukast/metabolites are excreted in human milk.</p><p>&nbsp;</p><p>Singulair may be used in breast-feeding only if it is considered to be clearly essential.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p>Singulair has no or negligible influence on the ability to drive and use machines. &nbsp;However, individuals have reported drowsiness or dizziness.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Montelukast has been evaluated in clinical studies as follows:</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->10 mg film-coated tablets in approximately 4,000 adult and adolescent asthmatic patients 15 years of age and older.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->10 mg film-coated tablets in approximately 400 adult and adolescent asthmatic patients with seasonal allergic rhinitis 15 years of age and older.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->5 mg chewable tablets in approximately 1,750 paediatric asthmatic patients 6 to 14 years of age.</p><p>&nbsp;</p><p>The following drug-related adverse reactions in clinical studies were reported commonly (&ge;1/100 to</p><p>&lt;1/10) in asthmatic patients treated with montelukast and at a greater incidence than in patients treated with placebo:</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:88.3pt; vertical-align:top; width:154.55pt"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Body System Class</strong></p></td><td style="border-color:black; height:88.3pt; vertical-align:top; width:165.0pt"><p>&nbsp;</p><p>&nbsp;</p><p><strong>Adult</strong><strong> </strong><strong>and Adolescent</strong><strong> </strong><strong>Patients 15 years and older</strong></p><p><strong>(two 12-week studies; n=795)</strong></p></td><td style="border-color:black; height:88.3pt; vertical-align:top; width:157.55pt"><p>&nbsp;</p><p><strong>Paediatric Patients 6 to 14 years old</strong></p><p><strong>(one</strong><strong> 8-week study; n=201) (two 56-week studies; n=615)</strong></p></td></tr><tr><td style="border-color:black; height:29.3pt; vertical-align:top; width:154.55pt"><p><strong>Nervous</strong><strong> system disorders</strong></p></td><td style="height:29.3pt; vertical-align:top; width:165.0pt"><p>headache</p></td><td style="height:29.3pt; vertical-align:top; width:157.55pt"><p>headache</p></td></tr><tr><td style="border-color:black; height:29.3pt; vertical-align:top; width:154.55pt"><p><strong>Gastro-intestinal</strong><strong> </strong><strong>disorders</strong></p></td><td style="height:29.3pt; vertical-align:top; width:165.0pt"><p>abdominal pain</p></td><td style="height:29.3pt; vertical-align:top; width:157.55pt"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>With prolonged treatment in clinical trials with a limited number of patients for up to 2 years for adults, and up to 12 months for paediatric patients 6 to 14 years of age, the safety profile did not change.</p><p>&nbsp;</p><p><u>Tabulated list of Adverse Reactions</u></p><p>Adverse reactions reported in post-marketing use are listed, by System Organ Class and specific Adverse Reactions, in the table below. Frequency Categories were estimated based on relevant clinical trials.</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:29.3pt; vertical-align:top; width:135.0pt"><p><strong>System</strong><strong> </strong><strong>Organ Class</strong></p></td><td style="border-color:black; height:29.3pt; vertical-align:top; width:2.75in"><p><strong>Adverse</strong><strong> Reactions</strong></p></td><td style="border-color:black; height:29.3pt; vertical-align:top; width:117.0pt"><p><strong>Frequency</strong><strong> Category*</strong></p></td></tr><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt"><p>Infections and infestations</p></td><td style="height:.2in; vertical-align:top; width:2.75in"><p>upper respiratory infection&dagger;</p></td><td style="height:.2in; vertical-align:top; width:117.0pt"><p>Very Common</p></td></tr><tr><td style="border-color:black; height:27.35pt; vertical-align:top; width:135.0pt"><p>Blood and lymphatic system disorders</p></td><td style="height:27.35pt; vertical-align:top; width:2.75in"><p>increased bleeding tendency</p></td><td style="height:27.35pt; vertical-align:top; width:117.0pt"><p>Rare</p></td></tr><tr><td style="height:27.35pt; vertical-align:top; width:135.0pt"><p>Immune system disorders</p></td><td style="height:27.35pt; vertical-align:top; width:2.75in"><p>hypersensitivity reactions including anaphylaxis</p></td><td style="height:27.35pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="border-color:black; height:13.45pt; vertical-align:top; width:135.0pt"><p>&nbsp;</p></td><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>hepatic eosinophilic infiltration</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="height:1.1in; vertical-align:top; width:135.0pt"><p>Psychiatric disorders</p></td><td style="height:1.1in; vertical-align:top; width:2.75in"><p>dream abnormalities including nightmares, insomnia, somnambulism, anxiety, agitation including aggressive behaviour or hostility, depression, psychomotor hyperactivity (including irritability, restlessness, tremor&sect;)</p></td><td style="height:1.1in; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="height:26.4pt; vertical-align:top; width:135.0pt"><p>&nbsp;</p></td><td style="height:26.4pt; vertical-align:top; width:2.75in"><p>disturbance in attention, memory impairment</p></td><td style="height:26.4pt; vertical-align:top; width:117.0pt"><p>Rare</p></td></tr><tr><td style="border-color:black; height:26.4pt; vertical-align:top; width:135.0pt"><p>&nbsp;</p></td><td style="height:26.4pt; vertical-align:top; width:2.75in"><p>hallucinations, disorientation, suicidal thinking and behaviour (suicidality)</p></td><td style="height:26.4pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="border-color:black; height:27.35pt; vertical-align:top; width:135.0pt"><p>Nervous system disorders</p></td><td style="height:27.35pt; vertical-align:top; width:2.75in"><p>dizziness, drowsiness, paraesthesia/hypoesthesia, seizure</p></td><td style="height:27.35pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt"><p>Cardiac disorders</p></td><td style="height:.2in; vertical-align:top; width:2.75in"><p>palpitations</p></td><td style="height:.2in; vertical-align:top; width:117.0pt"><p>Rare</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt" rowspan="3"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="border-color:black; height:.2in; vertical-align:top; width:2.75in"><p>epistaxis</p></td><td style="border-color:black; height:.2in; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="height:26.4pt; vertical-align:top; width:2.75in"><p>Churg-Strauss Syndrome (CSS) (see section 4.4)</p></td><td style="height:26.4pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>pulmonary eosinophilia</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt" rowspan="2"><p>Gastrointestinal disorders</p></td><td style="height:.2in; vertical-align:top; width:2.75in"><p>diarrhoea&Dagger;, nausea&Dagger;, vomiting&Dagger;</p></td><td style="height:.2in; vertical-align:top; width:117.0pt"><p>Common</p></td></tr><tr><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>dry mouth, dyspepsia</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="border-color:black; height:27.35pt; vertical-align:top; width:135.0pt" rowspan="2"><p>Hepatobiliary disorders</p></td><td style="height:27.35pt; vertical-align:top; width:2.75in"><p>elevated levels of serum transaminases (ALT, AST)</p></td><td style="height:27.35pt; vertical-align:top; width:117.0pt"><p>Common</p></td></tr><tr><td style="height:39.35pt; vertical-align:top; width:2.75in"><p>hepatitis (including cholestatic, hepatocellular, and mixed-pattern liver injury).</p></td><td style="height:39.35pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt" rowspan="4"><p>Skin and subcutaneous tissue disorders</p></td><td style="height:.2in; vertical-align:top; width:2.75in"><p>rash&Dagger;</p></td><td style="height:.2in; vertical-align:top; width:117.0pt"><p>Common</p></td></tr><tr><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>bruising, urticaria, pruritus</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>angiooedema</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Rare</p></td></tr><tr><td style="height:13.45pt; vertical-align:top; width:2.75in"><p>erythema nodosum, erythema multiforme</p></td><td style="height:13.45pt; vertical-align:top; width:117.0pt"><p>Very Rare</p></td></tr><tr><td style="border-color:black; height:27.35pt; vertical-align:top; width:135.0pt"><p>Musculoskeletal and connective tissue disorders</p></td><td style="height:27.35pt; vertical-align:top; width:2.75in"><p>arthralgia, myalgia including muscle cramps</p></td><td style="height:27.35pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="border-color:black; height:.2in; vertical-align:top; width:135.0pt" rowspan="2"><p>General disorders and administration site conditions</p></td><td style="height:.2in; vertical-align:top; width:2.75in"><p>pyrexia&Dagger;</p></td><td style="height:.2in; vertical-align:top; width:117.0pt"><p>Common</p></td></tr><tr><td style="height:25.9pt; vertical-align:top; width:2.75in"><p>asthenia/fatigue, malaise, oedema</p></td><td style="height:25.9pt; vertical-align:top; width:117.0pt"><p>Uncommon</p></td></tr><tr><td style="border-color:black; height:101.3pt; vertical-align:top; width:6.25in" colspan="3"><p>&nbsp;</p><p>*Frequency Category: Defined for each Adverse Reaction by the incidence reported in the clinical trials data base: Very Common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt;1/1,000), Very Rare (&lt;1/10,000).</p><p>&dagger;This adverse experience, reported as Very Common in the patients who received montelukast, was also reported as Very</p><p>Common in the patients who received placebo in clinical trials.</p><p>&Dagger;This adverse experience, reported as Common in the patients who received montelukast, was also reported as Common in the patients who received placebo in clinical trials.</p><p>&sect; Frequency Category: Rare</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via :</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Saudi Arabia: </u></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-20382222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><u>Other GCC States: </u></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In chronic asthma studies, montelukast has been administered at doses up to 200 mg/day to adult patients for 22 weeks and in short term studies, up to 900 mg/day to patients for approximately one week without clinically important adverse experiences.</p><p>&nbsp;</p><p>There have been reports of acute overdose in post-marketing experience and clinical studies with montelukast. These include reports in adults and children with a dose as high as 1,000 mg (approximately 61 mg/kg in a 42 month old child). The clinical and laboratory findings observed were consistent with the safety profile in adults and paediatric patients. There were no adverse experiences in the majority of overdose reports.</p><p>&nbsp;</p><p><u>Symptoms of overdose</u></p><p>The most frequently occurring adverse experiences were consistent with the safety profile of montelukast and included abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity.</p><p><u>&nbsp;</u></p><p><u>Management of overdose</u></p><p>No specific information is available on the treatment of overdose with montelukast. It is not known whether montelukast is dialysable by peritoneal- or haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p><strong>Pharmacotherapeutic</strong><strong> group: &nbsp;</strong>Leukotriene receptor antagonist</p><p><strong>ATC-code:</strong><strong> &nbsp;</strong>R03D C03</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>The cysteinyl leukotrienes (LTC4, LTD4, LTE4) are potent inflammatory eicosanoids released from various cells including mast cells and eosinophils. These important pro-asthmatic mediators bind to cysteinyl leukotriene (CysLT) receptors.&nbsp; The CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other</p><p>pro-inflammatory cells (including eosinophils and certain myeloid stem cells).&nbsp; CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.&nbsp; In asthma, leukotriene-mediated effects include bronchoconstriction, mucous secretion, vascular permeability, and eosinophil recruitment. In allergic rhinitis, CysLTs are released from the nasal mucosa after allergen exposure during both early- and late-phase reactions and are associated with symptoms of allergic rhinitis.</p><p>Intranasal challenge with CysLTs has been shown to increase nasal airway resistance and symptoms of nasal obstruction.</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1&nbsp;receptor. In clinical studies, montelukast inhibits bronchoconstriction due to inhaled LTD4&nbsp;at doses as low as 5 mg. Bronchodilation was observed within 2 hours of oral administration. The bronchodilation effect caused by a b-agonist was additive to that caused by montelukast. Treatment &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with montelukast inhibited both early- and late-phase bronchoconstriction due to antigen challenge.</p><p>Montelukast, compared with placebo, decreased peripheral blood eosinophils in adult and paediatric patients. In a separate study, treatment with montelukast significantly decreased eosinophils in the airways (as measured in sputum) and in peripheral blood while improving clinical asthma control.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>In studies in adults, montelukast, 10 mg once daily, compared with placebo, demonstrated significant improvements in morning FEV1&nbsp;(10.4% vs 2.7% change from baseline), AM peak expiratory flow rate (PEFR) (24.5 L/min vs 3.3 L/min change from baseline), and significant decrease in total b-agonist use (-26.1% vs -4.6% change from baseline).&nbsp; Improvement in patient-reported daytime and nighttime asthma symptoms scores was significantly better than placebo.</p><p>&nbsp;</p><p>Studies in adults demonstrated the ability of montelukast to add to the clinical effect of inhaled corticosteroid (% change from baseline for inhaled beclomethasone plus montelukast vs beclomethasone, respectively for FEV1: 5.43% vs 1.04%; b-agonist use: -8.70% vs 2.64%).</p><p>Compared with inhaled beclomethasone (200 mg twice daily with a spacer device), montelukast</p><p>demonstrated a more rapid initial response, although over the 12-week study, beclomethasone provided a greater average treatment effect (% change from baseline for montelukast vs beclomethasone, respectively for FEV1: 7.49% vs 13.3%; b-agonist use: -28.28% vs -43.89%). However, compared with beclomethasone, a high percentage of patients treated with montelukast achieved similar clinical responses (e.g., 50% of patients treated with beclomethasone achieved an</p><p>improvement in FEV1&nbsp;of approximately 11% or more over baseline while approximately 42% of patients treated with montelukast achieved the same response).</p><p>&nbsp;</p><p>A clinical study was conducted to evaluate montelukast for the symptomatic treatment of seasonal allergic rhinitis in adult and adolescent asthmatic patients 15 years of age and older with concomitant seasonal allergic rhinitis. In this study, montelukast 10 mg tablets administered once daily demonstrated a statistically significant improvement in the Daily Rhinitis Symptoms score, compared with placebo.&nbsp; The Daily Rhinitis Symptoms score is the average of the Daytime Nasal Symptoms score (mean of nasal congestion, rhinorrhea, sneezing, nasal itching) and the Nighttime Symptoms score (mean of nasal congestion upon awakening, difficulty going to sleep, and nighttime awakenings scores).&nbsp; Global evaluations of allergic rhinitis by patients and physicians were significantly improved, compared with placebo. The evaluation of asthma efficacy was not a primary objective in this study.</p><p>&nbsp;</p><p>In an 8-week study in paediatric patients 6 to 14 years of age, montelukast 5 mg once daily, compared with placebo, significantly improved respiratory function (FEV1&nbsp;8.71% vs 4.16% change from baseline; AM PEFR 27.9 L/min vs 17.8 L/min change from baseline) and decreased &ldquo;as-needed&rdquo;</p><p>b-agonist use (-11.7% vs +8.2% change from baseline).</p><p>&nbsp;</p><p>Significant reduction of exercise-induced bronchoconstriction (EIB) was demonstrated in a 12-week study in adults (maximal fall in FEV1&nbsp;22.33% for montelukast vs 32.40% for placebo; time to recovery to within 5% of baseline FEV1&nbsp;44.22 min vs 60.64 min). This effect was consistent throughout the 12-week study period. Reduction in EIB was also demonstrated in a short term study in paediatric patients (maximal fall in FEV1&nbsp;18.27% vs 26.11%; time to recovery to within 5% of baseline FEV1&nbsp;17.76 min vs 27.98 min).&nbsp; The effect in both studies was demonstrated at the end of the once-daily dosing interval.</p><p>&nbsp;</p><p>In aspirin-sensitive asthmatic patients receiving concomitant inhaled and/or oral corticosteroids, treatment with montelukast, compared with placebo, resulted in significant improvement in asthma control (FEV1&nbsp;8.55% vs -1.74% change from baseline and decrease in total b-agonist use -27.78% vs 2.09% change from baseline).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Montelukast is rapidly absorbed following oral administration. For the 10 mg film-coated tablet, the mean peak plasma concentration (Cmax) is achieved 3 hours (Tmax) after administration in adults in the fasted state.&nbsp; The mean oral bioavailability is 64%.&nbsp; The oral bioavailability and Cmax&nbsp;are not influenced by a standard meal.&nbsp; Safety and efficacy were demonstrated in clinical trials where the</p><p>10 mg film-coated tablet was administered without regard to the timing of food ingestion.</p><p>&nbsp;</p><p>For the 5 mg chewable tablet, the Cmax&nbsp;is achieved in 2 hours after administration in adults in the fasted state.&nbsp; The mean oral bioavailability is 73% and is decreased to 63% by a standard meal.</p><p>&nbsp;</p><p><u>Distribution</u></p><p>Montelukast is more than 99% bound to plasma proteins. The steady-state volume of distribution of montelukast averages 8-11 litres. Studies in rats with radiolabelled montelukast indicate minimal distribution across the blood-brain barrier. In addition, concentrations of radiolabelled material at 24 hours post-dose were minimal in all other tissues.</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>Montelukast is extensively metabolised. In studies with therapeutic doses, plasma concentrations of metabolites of montelukast are undetectable at steady state in adults and children.</p><p>Cytochrome P450 2C8 is the major enzyme in the metabolism of montelukast.&nbsp; Additionally CYP 3A4 and 2C9 may have a minor contribution, although itraconazole, an inhibitor of CYP 3A4, was shown not to change pharmacokinetic variables of montelukast in healthy subjects that received 10 mg montelukast daily. Based on <em>in vitro </em>results in human liver microsomes, therapeutic plasma concentrations of montelukast do not inhibit cytochromes P450 3A4, 2C9, 1A2, 2A6, 2C19, or 2D6. The contribution of metabolites to the therapeutic effect of montelukast is minimal.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The plasma clearance of montelukast averages 45 ml/min in healthy adults.&nbsp; Following an oral dose of radiolabeled montelukast, 86% of the radioactivity was recovered in 5-day faecal collections and</p><p>&lt;0.2% was recovered in urine.&nbsp; Coupled with estimates of montelukast oral bioavailability, this indicates that montelukast and its metabolites are excreted almost exclusively via the bile.</p><p>&nbsp;</p><p><u>Characteristics in Patients</u></p><p>No dosage adjustment is necessary for the elderly or mild to moderate hepatic insufficiency.&nbsp; Studies in patients with renal impairment have not been undertaken.&nbsp; Because montelukast and its metabolites are eliminated by the biliary route, no dose adjustment is anticipated to be necessary in patients with renal impairment. There are no data on the pharmacokinetics of montelukast in patients with severe hepatic insufficiency (Child-Pugh score &gt;9).</p><p>&nbsp;</p><p>With high doses of montelukast (20- and 60-fold the recommended adult dose), decrease in plasma theophylline concentration was observed.&nbsp; This effect was not seen at the recommended dose of</p><p>10 mg once daily.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal toxicity studies, minor serum biochemical alterations in ALT, glucose, phosphorus and triglycerides were observed which were transient in nature.&nbsp; The signs of toxicity in animals were increased excretion of saliva, gastrointestinal symptoms, loose stools and ion imbalance.&nbsp; These occurred at dosages which provided &gt;17-fold the systemic exposure seen at the clinical dosage. In monkeys, the adverse effects appeared at doses from 150 mg/kg/day (&gt;232-fold the systemic exposure seen at the clinical dose).&nbsp; In animal studies, montelukast did not affect fertility or reproductive performance at systemic exposure exceeding the clinical systemic exposure by greater than 24-fold.</p><p>A slight decrease in pup body weight was noted in the female fertility study in rats at 200 mg/kg/day (&gt;69-fold the clinical systemic exposure). In studies in rabbits, a higher incidence of incomplete ossification, compared with concurrent control animals, was seen at systemic exposure &gt;24-fold the clinical systemic exposure seen at the clinical dose.&nbsp; No abnormalities were seen in rats.&nbsp; Montelukast has been shown to cross the placental barrier and is excreted in breast milk of animals.</p><p>&nbsp;</p><p>No deaths occurred following a single oral administration of montelukast sodium at doses up to 5,000 mg/kg in mice and rats (15,000 mg/m2&nbsp;and 30,000 mg/m2&nbsp;in mice and rats, respectively), the maximum dose tested. This dose is equivalent to 25,000 times the recommended daily adult human dose (based on an adult patient weight of 50 kg).</p><p>&nbsp;</p><p>Montelukast was determined not to be phototoxic in mice for UVA, UVB or visible light spectra at doses up to 500 mg/kg/day (approximately &gt;200-fold based on systemic exposure).</p><p>&nbsp;</p><p>Montelukast was neither mutagenic in <em>in vitro </em>and <em>in vivo </em>tests nor tumorigenic in rodent species.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;</strong></p><p><!--[if !supportLists]--><strong>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><!--[endif]--><strong>List of excipients</strong></p><p>Microcrystalline cellulose Lactose monohydrate Croscarmellose sodium Hyprolose (E 463) Magnesium stearate</p><p>&nbsp;</p><p>Film coating: Hypromellose Hyprolose (E 463)</p><p>Titanium dioxide (E 171)</p><p>Red and yellow ferric oxide (E 172) Carnauba wax</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Packaged in polyamide/PVC/aluminium blister package in:</p><p>Blisters in packages of: &nbsp;7, 10, 14, 20, 28, 30, 50, 56, 84, 90, 98, 100, 140 and 200 tablets. Blisters (unit doses), in packages of: 49x1, 50x1 and 56x1 tablets.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorization Holder: 
Merck Sharp & Dohme Limited, Hertford Road,
Hoddesdon, Hertfordshire EN11 9BU,
UK.

Manufacturer:
Merck Sharp & Dohme Limited, Shotton Lane, 
Cramlington, Northumberland, NE23 3JU, 
UK.

Packed by:
Pharma Pharmaceutical Industries,
Second Industrial Area,
P.O. Box 11351 Riyadh, Saudi Arabia




            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                17 December 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>